Lehne's Pharmacology for Nursing
Care
12th Edition
• Author(s)Jacqueline Rosenjack
Burchum; Laura D. Rosenthal
,TEST BANK
1. Question Number and Type: 1 - MCQ
2. Clinical Scenario: A nurse is reviewing the properties of a
newly approved medication for hypertension during a staff
development session. The educator emphasizes the importance
of understanding what makes a drug "ideal."
3. Question Stem: The nurse educator states that an ideal drug
should primarily have which of the following properties?
4. Answer Options:
A) It should be affordable and available over-the-counter.
B) It should be effective, safe, and selective.
C) It should have a short half-life and be administered
intravenously.
D) It should be chemically stable and have a long shelf-life.
5. Correct Answer: B) It should be effective, safe, and selective.
6. Detailed Rationale: The concept of an "ideal drug" is a
fundamental, theoretical benchmark in pharmacology. An ideal
drug is defined by three primary
characteristics: effectiveness (it must produce the desired
therapeutic effect), safety (it should not produce harmful
effects, even at high doses), and selectivity (it should act only
,on the specific target cells or tissues, minimizing side effects).
While other properties like affordability and stability are
desirable, they are secondary to these core efficacy and safety
requirements, which are the foundation of the therapeutic
objective (maximizing benefit while minimizing harm).
7. Incorrect Option Analysis:
• A) It should be affordable and available over-the-
counter. Why It Is Incorrect: Affordability and availability
are important practical considerations for access and
adherence, but they are not defining properties of an
"ideal" drug from a pharmacological perspective. A drug
could be cheap and available but ineffective or
unsafe. Clinical Misconception: Confusing healthcare
access factors with pharmacologic properties. Medication
Safety Risk: Prioritizing cost over efficacy/safety could lead
to poor patient outcomes. Nursing Consideration: While
cost is a barrier to adherence, it does not make a drug
"ideal" pharmacologically.
• C) It should have a short half-life and be administered
intravenously. Why It Is Incorrect: A short half-life and IV
route are properties of specific drug formulations, not
characteristics of an ideal drug. A short half-life may
require frequent dosing, and IV administration is invasive.
These are neither universally desirable nor central to the
, definition. Clinical Misconception: Confusing
pharmacokinetic properties with the definition of an ideal
drug. Medication Safety Risk: An IV drug with a short half-
life could lead to rapid toxicity if not monitored
closely. Nursing Consideration: The ideal drug is effective
regardless of its pharmacokinetic profile; that profile
determines how it is used.
• D) It should be chemically stable and have a long shelf-
life. Why It Is Incorrect: This is a desirable manufacturing
property but not a primary characteristic of an ideal drug.
A drug could be stable but ineffective. Clinical
Misconception: Believing stability is the most important
property. Medication Safety Risk: An expired, unstable
drug could be ineffective or harmful. Nursing
Consideration: Stability is a factor in storage and handling,
not in the fundamental definition of an ideal drug.
8. Nursing Process Linkage: Evaluation (understanding drug
properties to evaluate therapy).
9. Clinical Judgment Competencies (NCJMM):
• Recognize Cues (Question asks for core properties of an
ideal drug).
• Analyze Cues (Differentiate between core pharmacologic
properties and practical considerations).
Care
12th Edition
• Author(s)Jacqueline Rosenjack
Burchum; Laura D. Rosenthal
,TEST BANK
1. Question Number and Type: 1 - MCQ
2. Clinical Scenario: A nurse is reviewing the properties of a
newly approved medication for hypertension during a staff
development session. The educator emphasizes the importance
of understanding what makes a drug "ideal."
3. Question Stem: The nurse educator states that an ideal drug
should primarily have which of the following properties?
4. Answer Options:
A) It should be affordable and available over-the-counter.
B) It should be effective, safe, and selective.
C) It should have a short half-life and be administered
intravenously.
D) It should be chemically stable and have a long shelf-life.
5. Correct Answer: B) It should be effective, safe, and selective.
6. Detailed Rationale: The concept of an "ideal drug" is a
fundamental, theoretical benchmark in pharmacology. An ideal
drug is defined by three primary
characteristics: effectiveness (it must produce the desired
therapeutic effect), safety (it should not produce harmful
effects, even at high doses), and selectivity (it should act only
,on the specific target cells or tissues, minimizing side effects).
While other properties like affordability and stability are
desirable, they are secondary to these core efficacy and safety
requirements, which are the foundation of the therapeutic
objective (maximizing benefit while minimizing harm).
7. Incorrect Option Analysis:
• A) It should be affordable and available over-the-
counter. Why It Is Incorrect: Affordability and availability
are important practical considerations for access and
adherence, but they are not defining properties of an
"ideal" drug from a pharmacological perspective. A drug
could be cheap and available but ineffective or
unsafe. Clinical Misconception: Confusing healthcare
access factors with pharmacologic properties. Medication
Safety Risk: Prioritizing cost over efficacy/safety could lead
to poor patient outcomes. Nursing Consideration: While
cost is a barrier to adherence, it does not make a drug
"ideal" pharmacologically.
• C) It should have a short half-life and be administered
intravenously. Why It Is Incorrect: A short half-life and IV
route are properties of specific drug formulations, not
characteristics of an ideal drug. A short half-life may
require frequent dosing, and IV administration is invasive.
These are neither universally desirable nor central to the
, definition. Clinical Misconception: Confusing
pharmacokinetic properties with the definition of an ideal
drug. Medication Safety Risk: An IV drug with a short half-
life could lead to rapid toxicity if not monitored
closely. Nursing Consideration: The ideal drug is effective
regardless of its pharmacokinetic profile; that profile
determines how it is used.
• D) It should be chemically stable and have a long shelf-
life. Why It Is Incorrect: This is a desirable manufacturing
property but not a primary characteristic of an ideal drug.
A drug could be stable but ineffective. Clinical
Misconception: Believing stability is the most important
property. Medication Safety Risk: An expired, unstable
drug could be ineffective or harmful. Nursing
Consideration: Stability is a factor in storage and handling,
not in the fundamental definition of an ideal drug.
8. Nursing Process Linkage: Evaluation (understanding drug
properties to evaluate therapy).
9. Clinical Judgment Competencies (NCJMM):
• Recognize Cues (Question asks for core properties of an
ideal drug).
• Analyze Cues (Differentiate between core pharmacologic
properties and practical considerations).
